GANNA STARKEY: Open Payments
NPI 1962848846 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,364 in 125 payments from 20 companies in 2025. Trend: 2023 $2,376 · 2024 $2,641 · 2025 $2,364
Food & beverage: $2,364
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $459 |
| Bayer Healthcare Pharmaceuticals Inc. | 15 | $284 |
| PFIZER INC. | 12 | $278 |
| GlaxoSmithKline, LLC. | 16 | $200 |
| Novo Nordisk Inc | 13 | $184 |
| Lilly USA, LLC | 10 | $183 |
| Axsome Therapeutics, Inc. | 6 | $146 |
| Abbott Laboratories | 7 | $120 |
| ABBVIE INC. | 5 | $114 |
| Janssen Pharmaceuticals, Inc | 5 | $94 |
Products named: Kerendia, NURTEC ODT, FARXIGA, TRELEGY ELLIPTA, MOUNJARO, Auvelity, FREESTYLE LIBRE 3, Ozempic.
Industry payments across OK — which companies pay providers there.
